Public health impact of drug resistant Plasmodium falciparum malaria
- 30 June 2005
- journal article
- review article
- Published by Elsevier BV in Acta Tropica
- Vol. 94 (3), 163-169
- https://doi.org/10.1016/j.actatropica.2005.04.015
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- The global distribution and population at risk of malaria: past, present, and futureThe Lancet Infectious Diseases, 2004
- Meeting international goals in child survival and HIV/AIDSThe Lancet, 2002
- Effect of 1997–98 EI Niño on highland malaria in TanzaniaThe Lancet, 2000
- Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan AfricaTropical Medicine & International Health, 1998
- Economic Implications of Resistance to Antimalarial DrugsPharmacoEconomics, 1996
- Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Indicators of Life-Threatening Malaria in African ChildrenNew England Journal of Medicine, 1995
- Alternative hypothesis for the evolution of chloroquine resistant Plasmodium falciparum in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Prevention of transfusion-associated HIV transmission in Kinshasa, ZaireAIDS, 1990